Novartis AG (NVS) Stock Analysis
NYSEHealthcareDrug Manufacturers - General
What Novartis AG does
Novartis AG is a holding company, which engages in the business of developing, manufacturing, and marketing healthcare products. Its product portfolio is heavily focused on innovative prescription medicines, especially oncology, immunology, neuroscience, and cardiovascular diseases, supplemented by established older brands and a wide range of specialized therapies. The company was founded on February 29, 1996 and is headquartered in Basel, Switzerland.
Key metrics
ETFs linked to NVS
Broad-market and Healthcare sector ETFs an investor holding Novartis AG is often also exposed to. Open an ETF page to see its actual top holdings.
PortView Portfolio Insights
PortView analyzes how NVS fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.
Analyze NVS in PortView →Similar companies
Frequently asked questions
- What is the ticker symbol for Novartis AG?
- Novartis AG trades under the ticker NVS on NYSE.
- Which exchange is NVS listed on?
- NVS is listed on NYSE.
- What sector does Novartis AG operate in?
- Novartis AG is classified in the Healthcare sector (Drug Manufacturers - General industry).
- How can PortView help analyze NVS in a portfolio?
- PortView shows NVS's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.
The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.